ArticleCase reports in oncology

Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies.

Quentin Perrier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.